# First Clinical Study of Erbium - Yttrium Aluminium Garnet (YAG) Laser Vaporization of Cutaneous Neurofibromas

> **NCT00921037** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 12 (estimated)

## Conditions studied

- Cutaneous Neurofibromas

## Interventions

- **PROCEDURE:** Erbium-YAG laser vaporization

## Key facts

- **NCT ID:** NCT00921037
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-04
- **Primary completion:** 2012-01
- **Final completion:** 2012-11
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2011-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00921037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00921037, "First Clinical Study of Erbium - Yttrium Aluminium Garnet (YAG) Laser Vaporization of Cutaneous Neurofibromas". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT00921037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*